| DBV TECHNOLOGIES EO -,10 |
| Frankreich |
| Gesundheit |
| FR0010417345 / A1JWB7 |
| DBV (Frankfurt) |
| FRA:DBV, ETR:DBV, DBV:GR |
| - |
| https://dbv-technologies... |
|
DBV Technologies SA is a clinical-stage French biopharmaceutical company headquartered in Bagneux, specializing in immunotherapy for food allergies. It pioneers the Viaskin technology, an epicutaneous..
>Volltext.. |
| 967.66 Mio. EUR |
| 921.75 Mio. EUR |
| - |
| -117.29 Mio. EUR |
| -114.57 Mio. EUR |
| -0.96 EUR |
| 13.85 Mio. EUR |
| 60.46 Mio. EUR |
| -90.28 Mio. EUR |
| 1.41 |
| - |
| -19.73% |
| - |
| - |
| - |
| - |
| DBV TECHNOLOGIES, DBV TECH |
| 27.03.26 |
|